MedPath

SUperior Hypogastric Plexus Block During Laparoscopic hysterEctomy (SUBTLE)

Not Applicable
Not yet recruiting
Conditions
Hysterectomy
Interventions
Procedure: Superior hypogastric plexus block
Registration Number
NCT06455540
Lead Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Brief Summary

This trial sest to assess the efficacy of a superior hypogastric plexus block (SHPB) for quality of recovery after a laparoscopic hysterectomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
198
Inclusion Criteria
  • Able to provide informed consent
  • Undergoing laparoscopic hysterectomy for benign indications
Exclusion Criteria
  • Planned procedure that requires dissection of the presacral space
  • Allergy to block medication (s)
  • Known or suspected malignancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Nerve blockSuperior hypogastric plexus blockThe superior hypogastric plexus block in this group will contain 20 mL of 0.75% ropivacaine hydrochloride.
Placebo blockSuperior hypogastric plexus blockThe superior hypogastric plexus block in this group will contain 20 mL of 0.9% normal saline.
Primary Outcome Measures
NameTimeMethod
Quality of recoveryPostoperative day 1

The Quality of recovery (QoR) 15 is a patient-reported outcome questionnaire that measures the quality of recovery after surgery.

Secondary Outcome Measures
NameTimeMethod
The McGill Pain QuestionnaireUp to postoperative day 90

The McGill Pain Questionnaire can be used to evaluate a person experiencing significant pain.

Postoperative Pain ScoresUp to postoperative day 2

Pain reported according to a visual rating scale from 0 to 100 points (0= no pain and 100= worst imaginable pain), which details their pain level using Visual Analog Scale (VAS) pain scores from the Brief Pain Inventory (BPI). Pain is reported on a scale of 1 to 100, and a higher score indicates greater pain intensity.

Postoperative Opioid UseUp to postoperative day 2

Postoperative opioid consumption during said time points

Quality of recoveryUp to postoperative day 2

The Quality of recovery (QoR) 15 is a patient-reported outcome questionnaire that measures the quality of recovery after surgery.

Postoperative nausea and vomitingUp to postoperative day 2

number of participants with nausea or vomiting

The Brief Pain Inventory (BPI)Up to postoperative day 90

The Brief Pain Inventory (BPI) is a self-administered questionnaire to assess the severity of pain and the impact of pain on the patient's daily functions.

Incidence of Adverse eventsIntraoperative (During block performance)

Incidence of adverse events related to the plexus block (vascular puncture, hematoma, and local anesthetic systemic toxicity (LAST))

Length of stay in post-anesthesia care unit (PACU) areaPostoperative day 1

Total time in PACU area

© Copyright 2025. All Rights Reserved by MedPath